NCT01353248 GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection Status COMPLETED Phase PHASE2
NCT01352416 Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery Status TERMINATED Phase PHASE3
NCT01349491 Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion Status TERMINATED Phase PHASE3
NCT01338636 An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE4
NCT01336686 Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout Status COMPLETED Phase PHASE2
NCT01334567 Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan Status COMPLETED Phase PHASE2
NCT01334203 A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) Status WITHDRAWN Phase PHASE4
NCT01329978 Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 Status COMPLETED Phase PHASE2
NCT01323933 First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01322932 Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey Status COMPLETED Phase N/A
NCT01320943 Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB Status COMPLETED Phase PHASE4
NCT01319253 A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies Status COMPLETED Phase N/A
NCT01316237 A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection Status COMPLETED Phase PHASE1
NCT01314716 Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE3
NCT01313624 Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE3
NCT01309243 Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults Status COMPLETED Phase PHASE3
NCT01306643 Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma Status COMPLETED Phase PHASE1/PHASE2